Teladoc Health to Participate in Upcoming Investor Conference
Rhea-AI Summary
Teladoc Health (NYSE: TDOC) announced that CEO Chuck Divita will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025 at 12:30 p.m. ET.
A live audio webcast and replay will be available via the company’s investor events page at http://ir.teladochealth.com/news-and-events/events-and-presentations/. Contact for investors is Michael Minchak at IR@teladochealth.com or 617-444-9612.
Positive
- None.
Negative
- None.
News Market Reaction – TDOC
In the Nov 28 session, TDOC gained 1.88%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 26 | Investor conference | Neutral | +1.9% | Announcement of CEO participation at Piper Sandler healthcare conference. |
| Nov 18 | Strategic partnership | Positive | +3.7% | TytoCare integration to enhance virtual primary and urgent care programs. |
| Nov 06 | Management compensation | Neutral | -1.2% | Equity inducement award for new CTO under NYSE Rule 303A.08. |
| Oct 29 | Earnings results | Negative | -1.6% | Q3 2025 revenue decline, net loss, and lower adjusted EBITDA. |
| Oct 23 | CFO transition | Neutral | +3.1% | CFO change with reaffirmed 2025 outlook and preliminary Q3 figures. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent TDOC news often produced modest single-digit moves, with negative fundamentals aligning with downside and neutral items (conferences, governance) sometimes seeing mixed follow-through.
Over the last few months, Teladoc Health has issued a mix of operational and investor-relations updates. An October 2025 CFO transition came alongside reaffirmed full-year guidance and preliminary Q3 figures. Formal Q3 2025 results on Oct 29 showed revenue of $626.4M and a net loss of $49.5M, drawing a negative reaction. Subsequent items included an inducement equity grant for the new CTO, a TytoCare integration announcement, and the current conference participation notice, which historically has driven only modest price moves.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Chuck Divita, chief executive officer, will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Investors:
Michael Minchak
IR@teladochealth.com
617-444-9612
